Related Experiment Video
Updated: Dec 27, 2025
Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease
Published on: April 19, 2015
Keep an eye on adenosine: Its role in retinal inflammation
Ana Raquel Santiago1, Maria H Madeira1, Raquel Boia2
1Faculty of Medicine, Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, 3000-548 Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal; Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, 3000-548 Coimbra, Portugal.
Adenosine, a key immune mediator, influences neuroinflammation in retinal diseases. Understanding its receptors and pathways offers new therapeutic targets for conditions like neurodegeneration.
Area of Science:
- Neuroscience
- Immunology
- Ophthalmology
Background:
- Adenosine is an endogenous nucleoside modulating immune responses via four G protein-coupled receptors (A1R, A2AR, A2BR, A3R).
- Neuroinflammation is implicated in chronic neurodegenerative and retinal degenerative diseases.
Purpose of the Study:
- To review the role of adenosine and its system in retinal neuroinflammation.
- To explore therapeutic potential for retinal diseases by understanding adenosine signaling.
Main Methods:
- Literature review focusing on adenosine, its receptors, enzymes, and transporters.
- Analysis of studies on animal models of retinal diseases and pathological conditions.
Main Results:
- The adenosinergic system is altered in retinal pathological conditions, impacting retinal physiology.
- Adenosine acts as a key mediator in immune responses relevant to retinal diseases.
Conclusions:
- Adenosine signaling pathways are crucial in the onset and progression of retinal diseases.
- Targeting the adenosinergic system presents a promising therapeutic strategy for retinal conditions.
More Related Videos
Related Concept Videos
01:30Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
01:31Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
01:27Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
01:26Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...